Published in Anesthesiology on July 01, 2013
Clinical use and the Italian demand for prothrombin complex concentrates. Blood Transfus (2013) 0.83
Case scenario: a patient on dual antiplatelet therapy with an intracranial hemorrhage after percutaneous coronary intervention. Anesthesiology (2014) 0.76
Neurosurgical procedures in patients with liver cirrhosis: A review. World J Hepatol (2015) 0.75
Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med (2011) 23.50
Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med (2005) 9.58
The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke (2001) 8.73
Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.94
Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med (2011) 7.30
Safety of recombinant activated factor VII in randomized clinical trials. N Engl J Med (2010) 6.81
Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. JAMA (1998) 5.37
Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke (1997) 4.55
The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med (2004) 3.63
CT angiography "spot sign" predicts hematoma expansion in acute intracerebral hemorrhage. Stroke (2007) 3.43
Intracranial hemorrhage in atrial fibrillation patients during anticoagulation with warfarin or dabigatran: the RE-LY trial. Stroke (2012) 3.02
Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol (2012) 2.94
Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation. Am J Cardiol (2012) 2.76
The increasing incidence of anticoagulant-associated intracerebral hemorrhage. Neurology (2007) 2.13
Evidence for activation of tissue factor by an allosteric disulfide bond. Biochemistry (2006) 1.99
Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial. Eur Heart J (2011) 1.98
Progression of mass effect after intracerebral hemorrhage. Stroke (1999) 1.90
Effect of tranexamic acid in traumatic brain injury: a nested randomised, placebo controlled trial (CRASH-2 Intracranial Bleeding Study). BMJ (2011) 1.87
Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors. Am J Hematol (2012) 1.85
Current concepts of hemostasis: implications for therapy. Anesthesiology (2004) 1.55
Rapid administration of antifibrinolytics and strict blood pressure control for intracerebral hemorrhage. Neurosurgery (2005) 1.43
Risk of postoperative hemorrhage after intracranial surgery after early nadroparin administration: results of a prospective study. Neurosurgery (2003) 1.42
Use of factor IX complex in warfarin-related intracranial hemorrhage. Neurosurgery (1999) 1.27
Elevation of platelet activating factor, inflammatory cytokines, and coagulation factors in the internal jugular vein of patients with subarachnoid hemorrhage. Neurochem Res (1997) 1.24
Interstitial glycerol as a marker for membrane phospholipid degradation in the acutely injured human brain. J Neurol Neurosurg Psychiatry (1998) 1.21
Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII? Stroke (2009) 1.16
Early coagulopathy after traumatic brain injury: the role of hypoperfusion and the protein C pathway. J Trauma (2007) 1.16
Anticoagulant-associated intracerebral hemorrhage. Semin Neurol (2011) 1.10
Sphingosine 1-phosphate contracts canine basilar arteries in vitro and in vivo: possible role in pathogenesis of cerebral vasospasm. Stroke (2001) 1.06
Review article: Coagulation cascade and therapeutics update: relevance to nephrology. Part 1: Overview of coagulation, thrombophilias and history of anticoagulants. Nephrology (Carlton) (2009) 1.00
Improved survival of patients with warfarin-associated intracerebral haemorrhage: a retrospective longitudinal population-based study. Int J Stroke (2012) 0.99
Tissue factor localization in non-human primate cerebral tissue. Thromb Haemost (1992) 0.96
Thrombolytic therapy for ischemic stroke--a review. Part I--Intravenous thrombolysis. Crit Care Med (2001) 0.93
Rapid warfarin reversal: a 3-factor prothrombin complex concentrate and recombinant factor VIIa cocktail for intracerebral hemorrhage. J Neurosurg (2011) 0.91
Hyperacute injury marker (HARM) in primary hemorrhage: a distinct form of CNS barrier disruption. Neurology (2011) 0.88
Do new oral anticoagulants require laboratory monitoring? The clinician point of view. Thromb Res (2012) 0.86
Therapeutic strategies in acute intracerebral hemorrhage. Neurotherapeutics (2012) 0.85
Treatment of acute intracerebral hemorrhage with epsilon-aminocaproic acid: a pilot study. Neurocrit Care (2004) 0.85
Reversal of vitamin K antagonist-associated coagulopathy: a survey of current practice. Thromb Res (2008) 0.81
Blister Aneurysms of the Internal Carotid Artery: Microsurgical Results and Management Strategy. Neurosurgery (2017) 0.79
Response to Journal Club: Validation of the Supplemented Spetzler-Martin Grading System for Brain Arteriovenous Malformations in a Multicenter Cohort of 1009 Surgical Patients. Neurosurgery (2016) 0.75
SYLVIAN FISSURE ARTERIOVENOUS MALFORMATIONS. Neurosurgery (2007) 0.75
Contralateral Anterior Interhemispheric Approach to Medial Frontal Arteriovenous Malformations: Surgical Technique and Results. Oper Neurosurg (Hagerstown) (2017) 0.75
Analysis of Cost Variation in Craniotomy for Tumor Using 2 National Databases. Neurosurgery (2017) 0.75
Advances in Open Microsurgery for Cerebral Aneurysms. Neurosurgery (2014) 0.75